ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (HKG:1541)
3.520
+0.090 (2.62%)
Jul 10, 2026, 10:53 AM HKT
-69.60% (1Y)
| Market Cap | 1.48B -73.1% |
| Revenue (ttm) | 171.70M +108.1% |
| Net Income | -243.24M |
| EPS | -0.59 |
| Shares Out | 431.51M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 77,600 |
| Open | 3.450 |
| Previous Close | 3.430 |
| Day's Range | 3.410 - 3.520 |
| 52-Week Range | 2.800 - 16.800 |
| Beta | 0.22 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 21, 2026 |